Update on in vitro cytotoxicity assays for drug development.
about
Labeling live cells by copper-catalyzed alkyne--azide click chemistryHsp70 Isoforms Are Essential for the Formation of Kaposi's Sarcoma-Associated Herpesvirus Replication and Transcription CompartmentsIn vitro viability and cytotoxicity testing and same-well multi-parametric combinations for high throughput screeningMiniaturized pre-clinical cancer models as research and diagnostic tools.Evaluation of impermeant, DNA-binding dye fluorescence as a real-time readout of eukaryotic cell toxicity in a high throughput screening format.DNA methylation topology: potential of a chromatin landmark for epigenetic drug toxicology.Interferences in the Optimization of the MTT Assay for Viability Estimation of Proteus mirabilisAnticancer metal complexes: synthesis and cytotoxicity evaluation by the MTT assay.Assessment of cytotoxicity, genotoxicity and 7-ethoxyresorufin-O-deethylase (EROD) induction in sediment extracts from New Zealand urban estuaries.High Throughput, Real-time, Dual-readout Testing of Intracellular Antimicrobial Activity and Eukaryotic Cell Cytotoxicity.Altered cytotoxicity of ROS-inducing compounds by sodium pyruvate in cell culture medium depends on the location of ROS generation.Cyclodextrin-polysaccharide-based, in situ-gelled system for ocular antifungal delivery.A new approach to drug discovery: high-throughput screening of microbial natural extracts against Aspergillus fumigatus using resazurin.Determination of Metabolic Viability and Cell Mass Using a Tandem Resazurin/Sulforhodamine B Assay.Interdependence of initial cell density, drug concentration and exposure time revealed by real-time impedance spectroscopic cytotoxicity assay.Controlled-release formulation of perindopril erbumine loaded PEG-coated magnetite nanoparticles for biomedical applications
P2860
Q24606444-694D82B2-71A9-4865-AF70-8B53AEF9D9BEQ28551082-89779FEA-5DE1-437C-A916-D87BC64FE816Q33576021-891AD0CB-C444-4E85-A230-34D6FBDFDE2DQ33605145-DD210DF4-553F-4966-B913-AC78482FCFD4Q33632066-678B389C-E1FB-4714-BACE-4D91ABB2BFA7Q35647894-0270E3B8-62F6-4AAC-BFE2-4C5FC40DAC8EQ36238707-66521662-95C4-40B7-B828-4EB435E4483BQ38795822-52C52FF3-EC8C-460E-9DF1-78E38D8566D4Q39022957-E93466A4-CE5A-4737-A15E-45A39A452833Q40425452-D854275D-E6A4-4094-A542-3B5C15F9E64FQ40820830-0DD89DD9-80ED-4427-A89D-B798FDF0C11EQ41843480-A1AB05BD-3D10-4352-8988-933B7EC94359Q50260762-6BE91B9D-D3C4-45A8-81FE-1669ABBF18B7Q53107278-BB0F93BF-3E53-4139-B448-4084DD4708A5Q53544640-A20DC9E2-4D9E-450E-8B52-EC83E0C974ECQ59318878-11735B20-760B-493A-853C-E4712A7BB1C3
P2860
Update on in vitro cytotoxicity assays for drug development.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh-hant
name
Update on in vitro cytotoxicity assays for drug development.
@en
Update on in vitro cytotoxicity assays for drug development.
@nl
type
label
Update on in vitro cytotoxicity assays for drug development.
@en
Update on in vitro cytotoxicity assays for drug development.
@nl
prefLabel
Update on in vitro cytotoxicity assays for drug development.
@en
Update on in vitro cytotoxicity assays for drug development.
@nl
P2093
P2860
P356
P1476
Update on in vitro cytotoxicity assays for drug development.
@en
P2093
Andrew L Niles
Richard A Moravec
Terry L Riss
P2860
P304
P356
10.1517/17460441.3.6.655
P407
P577
2008-06-01T00:00:00Z